Who
Jonathan B. Zung
Cdo
Company insider
Files Form 4 as: Cdo, Curis; Chief Development Officer, Evelo Biosciences.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 27 Jan 2021
- Last trade
- 7 Jul 2026
- Last filed
- 9 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Jul 2026filed 9 Jul 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $255K48,285 at $5.29 | filing |
| 7 Jul 2026filed 9 Jul 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $255K48,285 at $5.29 | filing |
| 20 Mar 2026filed 23 Mar 2026 | CRIS CurisBiotechnology | SEC FORM 4 Code C | —66,667 | filing |
| 20 Mar 2026filed 23 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code C | —50 | filing |
| 20 Mar 2026filed 23 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code C | —50 | filing |
| 20 Mar 2026filed 23 Mar 2026 | CRIS CurisBiotechnology | SEC FORM 4 Code C | —66,667 | filing |
| 17 Mar 2026filed 18 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —50 | filing |
| 17 Mar 2026filed 18 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,667 | filing |
| 17 Mar 2026filed 18 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,667 | filing |
| 17 Mar 2026filed 18 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —50 | filing |
| 17 Mar 2026filed 18 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,667 | filing |
| 17 Mar 2026filed 18 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,667 | filing |
| 17 Mar 2026filed 18 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,667 | filing |
| 17 Mar 2026filed 18 Mar 2026 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,667 | filing |
| 20 May 2025filed 22 May 2025 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $423K135,000 at $3.13 | filing |
| 28 Jan 2025filed 30 Jan 2025 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $47K15,000 at $3.13 | filing |
| 21 May 2024filed 23 May 2024 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $473K40,700 at $11.62 | filing |
| 1 May 2023filed 3 May 2023 | CRIS Curisoption or derivative · Biotechnology | SEC FORM 4 Code A | $415K500,000 at $0.83 | filing |
| 19 Jul 2022filed 14 Oct 2022 | Evelo Biosciencesoption or derivative | SEC FORM 4 Code A | —115,000 at $0.00 | filing |
| 19 Jan 2022filed 21 Jan 2022 | Evelo Biosciencesoption or derivative | SEC FORM 4 Code A | —115,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.